Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model.
Koutrafouri. V V; Leondiadis. L L; Avgoustakis. K K; Livaniou. E E; Czarnecki. J J; Ithakissios. D S DS; Evangelatos. G P GP
Key Findings
- Tα1 enhanced angiogenesis in the chick chorioallantoic membrane assay
- Other thymosin peptides (Tβ10, Tβ9, ParaTα) inhibited angiogenesis
- Increasing Tβ10 levels counteracted the proāangiogenic effect of Tβ4, showing doseādependent balance
Practical Outcomes
- Tα1 could be considered for experimental use in woundāhealing or recovery protocols, but human dosing and safety are not established. The effective range in the study (ā0.016ā6.66āÆnmol in 10āÆĀµL) cannot be directly applied to people, so any trial should start with very low, cautious doses and monitor outcomes.
Summary
The study shows that thymosin alphaā1 (Tα1) can boost new bloodāvessel growth in a chick embryo model, while some other thymosin peptides block this process. This suggests Tα1 might help with tissue repair, but the work is earlyāstage and done in animals, not humans.
Abstract
The effect of alpha- and beta-thymosin peptides, namely prothymosin alpha (ProT(alpha)), thymosin alpha(1) (T(alpha)1), parathymosin alpha (ParaT(alpha)), thymosin beta(4) (Tbeta4), thymosin beta(10) (Tbeta10), and thymosin beta(9) (Tbeta9), on the angiogenesis process was investigated using the chick chorioallantoic membrane as an in vivo angiogenesis model. The thymosin peptides tested were applied in 10 microl aliquots containing 0.01-4 nmoles of Tbeta4, Tbeta10 or Tbeta9, 0.016-6.66 nmoles of T(alpha)1, 4.1 pmoles-1.66 nmoles of ProT(alpha), and 4.4 pmoles-1.76 nmoles of ParaT(alpha). Phorbol 12-myristate 13-acetate and hydrocortisone were also used as positive and negative control, respectively. Tbeta4, ProT(alpha) and T(alpha)1 were found to enhance angiogenesis, while Tbeta10, Tbeta9 and ParaT(alpha) exhibited an inhibitory effect on the angiogenesis process. When mixtures of Tbeta4 and Tbeta10 containing active amounts of the two peptides at different proportions were applied, the promoting effect of Tbeta4 on angiogenesis was reversed in the presence of increasing concentrations of Tbeta10 and vice versa. The effect of Tbeta10, Tbeta9, ProT(alpha) and ParaT(alpha), in parallel with Tbeta4 and T(alpha)1, on the angiogenesis process was investigated for the first time as far as we know and the results of this study offer more insight into the biological regulatory roles of thymosin peptides, and provide helpful information about their therapeutic potential. Whether these agents could be used either as inhibitors of angiogenesis in disease states where uncontrolled angiogenesis is involved, e.g. in carcinogenesis, or as angiogenesis promoters that could be useful in wound healing, fracture repair, peptic ulcers etc., remains to be further studied.
Study Information
pubmed
2001
2001-11-07T00:00:00.000Z
10.1016/s0304-4165(01)00200-8